• SENSEX
    NIFTY 50
Healthcare

Novartis to buy AveXis for $8.7 billion

Updated : April 09, 2018 10:55 AM IST

The Novartis offer represents a premium of 88% to AveXis’ closing price on April 6, 2018.
AveXis' drug AVXS-101 granted orphan drug designation, approval and launch expected in 2019.
Novartis to buy AveXis for $8.7 billion

You May Also Like

Live TV

recommended for you

Advertisement